230 related articles for article (PubMed ID: 34455485)
1. Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides.
Yadav V; Jobe N; Mehdawi L; Andersson T
Handb Exp Pharmacol; 2021; 269():279-303. PubMed ID: 34455485
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.
Yang G; Shen T; Yi X; Zhang Z; Tang C; Wang L; Zhou Y; Zhou W
J Cell Mol Med; 2018 Apr; 22(4):2062-2070. PubMed ID: 29392884
[TBL] [Abstract][Full Text] [Related]
3. Unlocking the Wnt pathway: Therapeutic potential of selective targeting FZD
Larasati Y; Boudou C; Koval A; Katanaev VL
Drug Discov Today; 2022 Mar; 27(3):777-792. PubMed ID: 34915171
[TBL] [Abstract][Full Text] [Related]
4. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
Nguyen VHL; Hough R; Bernaudo S; Peng C
J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders.
Caspi M; Wittenstein A; Kazelnik M; Shor-Nareznoy Y; Rosin-Arbesfeld R
Adv Drug Deliv Rev; 2021 Feb; 169():118-136. PubMed ID: 33346022
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
8. Dickkopfs and Wnt/β-catenin signalling in liver cancer.
Fatima S; Lee NP; Luk JM
World J Clin Oncol; 2011 Aug; 2(8):311-25. PubMed ID: 21876852
[TBL] [Abstract][Full Text] [Related]
9. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
10. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
11. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
12. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research.
Wang K; Li N; Yeung CH; Li JY; Wang HY; Cooper TG
Mol Hum Reprod; 2013 Feb; 19(2):57-71. PubMed ID: 23155044
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy.
Li J; Ji L; Chen J; Zhang W; Ye Z
Biomed Res Int; 2015; 2015():964842. PubMed ID: 26078973
[TBL] [Abstract][Full Text] [Related]
15. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.
Driehuis E; Clevers H
Br J Pharmacol; 2017 Dec; 174(24):4547-4563. PubMed ID: 28244067
[TBL] [Abstract][Full Text] [Related]
16. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.
Zhan T; Ambrosi G; Wandmacher AM; Rauscher B; Betge J; Rindtorff N; Häussler RS; Hinsenkamp I; Bamberg L; Hessling B; Müller-Decker K; Erdmann G; Burgermeister E; Ebert MP; Boutros M
Nat Commun; 2019 May; 10(1):2197. PubMed ID: 31097693
[TBL] [Abstract][Full Text] [Related]
17. Patent landscape highlighting double-edged scaffold of a WNT5A-agonizing peptide, Foxy5.
Yadav V; Islam R; Tuli HS
Pharm Pat Anal; 2023 Mar; 12(2):69-77. PubMed ID: 37078761
[TBL] [Abstract][Full Text] [Related]
18. AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling.
Chi J; Zhang H; Hu J; Song Y; Li J; Wang L; Wang Z
Cell Signal; 2020 Jan; 65():109419. PubMed ID: 31526829
[TBL] [Abstract][Full Text] [Related]
19. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
Wang J; Shibayama Y; Zhang A; Ohsaki H; Asano E; Suzuki Y; Kushida Y; Kobara H; Masaki T; Wang Z; Nishiyama A
Br J Cancer; 2019 Jan; 120(2):229-237. PubMed ID: 30555158
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signalling in prostate cancer.
Kypta RM; Waxman J
Nat Rev Urol; 2012 Aug; 9(8):418-28. PubMed ID: 22710668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]